Study to Evaluate Safety and Effects of Tofacitinib and Biologic Disease Modifying Antirheumatic Drugs in People Treated for Rheumatoid Arthritis

NCT05572567 · clinicaltrials.gov ↗
COMPLETED
Status
1972
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

Pfizer